Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy
Anne M. A. Tryggestad
◽
Karol Axcrona
◽
Ulrika Axcrona
◽
Iris Bigalke
◽
Bjørn Brennhovd
◽
...
Anne Merete Tryggestad
◽
Iris Bigalke
◽
Karol Axcrona
◽
Bjørn Brennhovd
◽
T Kirsti Hønnåshagen
◽
...
2017 ◽
Vol 19
(5)
◽
pp. S15
◽
A.A. Tryggestad
◽
I. Bigalke
◽
K. Axcrona
◽
E. Inderberg
◽
G. Skorstad
◽
...
2013 ◽
Vol 12
(4)
◽
pp. e1258, C150
C.K. Kobajlo
◽
J.A. Adamowicz
◽
Z.W. Wolski
2010 ◽
Vol 84
(2)
◽
pp. 164-173
◽
Martin Spahn
◽
Christel Weiss
◽
Pia Bader
◽
Philipp Ströbel
◽
Elmar W. Gerharz
◽
...
2015 ◽
Vol 14
(2)
◽
pp. e1013-e1013a
M. Bianchi
◽
R.J. Karnes
◽
S. Joniau
◽
G. Gandaglia
◽
M. Spahn
◽
...
2018 ◽
Vol 42
(8)
◽
pp. 507-515
J. Rubio-Briones
◽
M. Ramírez-Backhaus
◽
A. Gómez-Ferrer
◽
C. Mir
◽
J. Domínguez-Escrig
◽
...
2014 ◽
Vol 13
(2)
◽
pp. e1189
A. Nosov
◽
S. Petrov
◽
S. Reva
◽
E. Mamijev
◽
R. Novikov
Hajime Onuma
◽
Takahiro Kimura
◽
Kojiro Tashiro
◽
Yasutoshi Yoshiyama
◽
Masahito Kido
◽
...
2008 ◽
Vol 179
(4S)
◽
pp. 552-553
◽
Stephen A Boorjian
◽
R Jeffrey Karnes
◽
Laureano J Rangel
◽
Eric J Bergstralh
◽
Michael L Blute
Daimantas Milonas
◽
Žilvinas Venclovas
◽
Inga Gudinaviciene
◽
Stasys Auskalnis
◽
Kristina Zviniene
◽
...